Johnson & Johnson (J&J) has received the CE Mark for its ACUVUE OASYS MAX 2-Week, a new reusable contact lens featuring MAX technologies.
The lens is set to launch in select European countries later this year, with a broader rollout planned for 2027 and 2028, subject to regulatory approvals and market conditions.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
J&J states that comfort and visual clarity remain significant factors for those choosing contact lenses, especially as daily exposure to digital devices and blue-violet light increases.
These trends place added demands on users’ eyes, which may lead to discomfort and reduced clarity.
The ACUVUE OASYS MAX 2-Week lens reportedly incorporates technologies to address these challenges.
Features include the OptiBlue Light Filter, which filters at least 60% of blue-violet light, TearStable Technology aimed at maintaining eye moisture, and Class 1 UV blocking to help shield eyes from radiation, including sunlight.
The technologies combine to support vision clarity during activities such as digital device use, outdoor pursuits, and night driving.
For practitioners, J&J designed the lens to be compatible with the existing fitting process used for ACUVUE OASYS 2-Week lenses.
J&J MedTech vision company group chair Jacqueline Henderson said: “People who choose reusable contact lenses should not have to compromise on comfort or clarity as their days get busier and their eyes work harder.
“With ACUVUE OASYS MAX 2-Week, we are bringing our most advanced ACUVUE technologies to a reusable lens, helping more people see clearly and feel comfortable throughout the full two-week wear cycle.”
ACUVUE OASYS MAX 2-Week forms part of the ACUVUE OASYS MAX contact lens portfolio, which is intended to offer advanced options for reusable lens users.
In July, J&J secured approval from the US Food and Drug Administration for its Dual Energy Thermocool Smarttouch SF Platform.
